Get started
Author

Pierpaolo Correale

In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen
1997 · P. Correale, C. Nieroda, et al. · JNCI Journal of the National Cancer Institute · 267
Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
2010 · Pierpaolo Correale, Maria Saveria Rotundo, et al. · Journal of Immunotherapy · 218
Chemo-Immunotherapy of Metastatic Colorectal Carcinoma With Gemcitabine Plus FOLFOX 4 Followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Induces Strong Immunologic and Antitumor Activity in Metastatic Colon Cancer Patients
2005 · Pierpaolo Correale, Maria Grazia Cusi, et al. · Journal of Clinical Oncology · 171
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials
2012 · Domenico Ciliberto, Cirino Botta, et al. · European Journal of Cancer · 125
Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide
1998 · Pierpaolo Correale, Konstantin Walmsley, et al. · The Journal of Immunology · 121
Adjuvant Epirubicin With or Without Ifosfamide for Adult Soft-Tissue Sarcoma
2002 · Roberto Petrioli, Andrea Coratti, et al. · American Journal of Clinical Oncology · 118
HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy
2020 · Pierpaolo Correale, Luciano Mutti, et al. · International Journal of Molecular Sciences · 109
PDF
Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects
2020 · Sara Tenti, Pierpaolo Correale, et al. · International Journal of Molecular Sciences · 103
PDF
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients
2016 · EC Martino, G Misso, et al. · Cell Death Discovery · 94
PDF
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
2013 · Cirino Botta, Vito Barbieri, et al. · Cancer Biology & Therapy · 92
PDF
Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
2011 · Pierpaolo Correale, Maria Saveria Rotundo, et al. · Clinical Cancer Research · 91
Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A(*)02.01 restricted, CEA‐peptide‐specific cytotoxic T cells in vitro
2003 · Pierpaolo Correale, Angelo Aquino, et al. · International Journal of Cancer · 84
Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response in vitro
2011 · P. Correale, C. Botta, et al. · International Journal of Cancer · 83
PDF
Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)
2008 · Pierpaolo Correale, Pierosandro Tagliaferri, et al. · Clinical Cancer Research · 81
PDF
Delta-radiomics increases multicentre reproducibility: a phantom study
2020 · Valerio Nardone, Alfonso Reginelli, et al. · Medical Oncology · 80
Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity
2020 · Paola Gualtieri, Carmela Falcone, et al. · International Journal of Molecular Sciences · 74
PDF
Dendritic Cell-Mediated Cross-Presentation of Antigens Derived from Colon Carcinoma Cells Exposed to a Highly Cytotoxic Multidrug Regimen with Gemcitabine, Oxaliplatin, 5-Fluorouracil, and Leucovorin, Elicits a Powerful Human Antigen-Specific CTL Response with Antitumor Activity in Vitro
2005 · Pierpaolo Correale, Maria Grazia Cusi, et al. · The Journal of Immunology · 73
PDF
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse
2016 · Valerio Nardone, Cirino Botta, et al. · Cancer Biology & Therapy · 72
PDF
Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities
2014 · Cirino Botta, Annamaria GullÃ, et al. · Frontiers in Oncology · 72
PDF
Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.
1997 · K Y Tsang, M Zhu, et al. · PubMed · 71
Radiomics predicts survival of patients with advanced non‑small cell lung cancer undergoing PD‑1 blockade using Nivolumab
2019 · Valerio Nardone, Paolo Tini, et al. · Oncology Letters · 70
PDF
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects
2010 · Maria Grazia Cusi, Barbara Martorelli, et al. · Immunity & Ageing · 68
PDF
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC)
2010 · Pierpaolo Correale, Monica Marra, et al. · European Journal of Cancer · 68
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
2017 · C Botta, M Cucè, et al. · Leukemia · 67
PDF
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients
2010 · B. Vincenzi, S. Galluzzo, et al. · Annals of Oncology · 66
PDF
Works count: 228
Citation count: 5,513
H-index: 44
I10-index: 122
Year
Topic
Type